Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.
about
Locoregional treatment of early breast cancer with isolated tumor cells or micrometastases on sentinel lymph node biopsyAxillary surgery in women with sentinel node-positive operable breast cancer: a systematic review with meta-analysesLandmark trials affecting the surgical management of invasive breast cancerCurrent trends in breast surgeryThe evolution of the locoregional therapy of breast cancerMapping lymph nodes in cancer management - role of (99m)Tc-tilmanocept injectionAxillary lymph nodes in breast cancer patients: sonographic evaluationMain controversies in breast cancerManagement of Axilla in 2015 in Indian ScenarioAxillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts.Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015).AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011.Local and regional staging of invasive breast cancer with sonography: 25 years of practice at MD Anderson Cancer Center.Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients.Modern therapeutic concepts of early breast cancer.Local treatment of the axilla in early breast cancer: concepts from the national surgical adjuvant breast and bowel project B-04 to the planned intergroup sentinel mamma trialDisease recurrence in sentinel node-positive breast cancer patients forgoing axillary lymph node dissection.Staging the axilla in women with breast cancer: the utility of preoperative ultrasound-guided needle biopsy.Axillary lymph node dissection on the run?Management of sentinel node re-mapping in patients who have second or recurrent breast cancer and had previous axillary procedures.Sentinel lymph node micrometastases and isolated tumor cells in breast cancer: an evolving fieldAxillary dissection versus no axillary dissection in patients with sentinel-node micrometastases: commentary on the IBCSG 23-01 Trial.Sentinel lymph node biopsy in breast cancer: predictors of axillary and non-sentinel lymph node involvement.Advances in managing breast cancer: a clinical updateDifferential gene expression in primary breast tumors associated with lymph node metastasis.Patterns of nodal staging during breast conservation surgery in the medicare patient: will the ACOSOG Z0011 trial change the pattern of care?Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: a meta-analysis.Risk of node metastasis of sentinel lymph nodes detected in level II/III of the axilla by single-photon emission computed tomography/computed tomographyBreast radiotherapy (RT) using tangential fields (TgF): a prospective evaluation of the dose distribution in the sentinel lymph node (SLN) area as determined intraoperatively by clip placement.Intraoperative radiation therapy: a critical analysis of the ELIOT and TARGIT trials. Part 1--ELIOT.Computed tomography Hounsfield units can predict breast cancer metastasis to axillary lymph nodes.Clinical outcomes after sentinel lymph node biopsy in clinically node-negative breast cancer patients.Preoperative MRI improves prediction of extensive occult axillary lymph node metastases in breast cancer patients with a positive sentinel lymph node biopsy.Radiation field design in the ACOSOG Z0011 (Alliance) TrialNew concepts in axillary management of breast cancerMeeting highlights: the first korean breast cancer treatment consensus conference.Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy.Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trialBiopathologic features and clinical significance of micrometatasis in the lymph node of early gastric cancer
P2860
Q26747688-7E2645B6-F512-4196-A439-4064D254FBA8Q26768675-55408A5C-4335-4D43-92A1-EC01D9EE2775Q26830129-9FC41C33-AE35-4FBD-A757-04E8B9575654Q26853309-06956068-FF6B-45E5-8677-3BC9FAF1C8D4Q26992321-AEF82BA6-4D82-4CE5-8121-365B919B8A31Q27022042-A04A668C-C2BB-459A-95E4-3587A5D9DE6EQ27025067-2892A3FA-FBD2-4FDE-8F36-CEB80B67D4D6Q27026673-19238C3E-B6E1-4F6B-82D7-1833086BF4A4Q28079495-5B1F4E63-8EBC-4D9D-9E27-2F3DA92B65BFQ28305038-5DDC178A-29DD-46E8-AA24-1B31DE41B98FQ30315970-333D708A-671C-4E6B-9064-AEB70F6F9169Q30316383-22762A84-E187-424D-A367-DE63DA367028Q30318240-D3E7A650-44D4-4A6C-820F-1C91D4D330BEQ30569178-4C79DF98-DBBF-416E-BA37-82946A566778Q33571995-62860259-C7FE-41A0-A9E9-EDBBB7BA44EDQ33684849-B7E9636D-DCD9-45DC-8727-150EA3871D6BQ33684856-0E780445-6E27-41AF-B71E-D93DAAD53B65Q33705413-5F0D3457-3BD8-44E8-A0BD-620B978E8D9FQ33802478-2E71384F-FD40-4A04-A810-B4750358E619Q33896875-1DD6BC58-E4CA-4FF0-98AA-56DB13722C60Q33939588-8823B25B-64E7-413C-97D1-20F7B39A151DQ33972921-4D3AF202-C524-4900-A6B2-2FCE64590802Q33973078-E60F1F04-E036-4BE6-839E-834196D92597Q33974092-E99BA758-A10F-4D3B-AF27-B1F41B5412D1Q34019904-F2F64B2B-5DCD-49D8-8443-D5D299F29310Q34147751-493D9D65-6A5D-4F4D-A8FF-CCBE76694BC9Q34164742-41FB6D88-0B36-4D3C-BA67-5686E5070742Q34165928-14C2FD84-BB39-4ED2-94BF-99E6ACE11DBEQ34292423-FBBD48E2-F45D-4598-9F87-FC0DE5DED0DAQ34303444-2484792B-046F-4562-A27C-CB0F6072ED52Q34303451-D5D0AC23-D50F-42DA-8426-FCAC7614F884Q34320273-35E8718C-F888-4969-A51C-3926A879E168Q34325446-FF891759-E01A-4B16-BA64-4F1C8B161111Q34401140-B6A9308F-6B96-458B-9CD8-39FAAD2DC170Q34451764-7CA7CC37-B41B-449D-82F5-96CFC571F895Q34657725-6A58D949-95E5-4F10-B163-5DC498F5882DQ34779593-B791FF3F-5F79-4B49-9AD7-5258A4B4B4BDQ34781406-EF4F1D4F-5609-4C90-AE6D-A8E2ED2FFAA6Q34919537-9D1E87A0-E640-49EA-BD49-34510511275CQ34932726-5FE96D92-0AA2-43BA-A3EB-646EEB07CAC2
P2860
Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Locoregional recurrence after ...... Group Z0011 randomized trial.
@en
type
label
Locoregional recurrence after ...... Group Z0011 randomized trial.
@en
prefLabel
Locoregional recurrence after ...... Group Z0011 randomized trial.
@en
P2093
P2860
P1433
P1476
Locoregional recurrence after ...... Group Z0011 randomized trial.
@en
P2093
A Marilyn Leitch
Armando E Giuliano
Karla Ballman
Kelly K Hunt
Linda McCall
Pat W Whitworth
Peter Beitsch
Peter Blumencranz
Sukamal Saha
P2860
P304
426-32; discussion 432-3
P356
10.1097/SLA.0B013E3181F08F32
P407
P577
2010-09-01T00:00:00Z